MABVAX THERAPEUTICS HLDGS IN's ticker is MBVX and the CUSIP is 55414P504. A total of 10 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 26,708 | $61,000 | 0.11% |
| Delaney Dennis R | 10,000 | $23,000 | 0.05% |
| WELLS FARGO & COMPANY/MN | 3 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,373 | $46,000 | 0.00% |
| DEUTSCHE BANK AG\ | 3 | $0 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 7 | $0 | 0.00% |
| UBS Group AG | 4,957 | $11,000 | 0.00% |
| Sargent Bickham Lagudis LLC | 2 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |